Qiming Li, Jiaqi Li, Yanyang Zhao, Shuai Guo, Mengzhe Liu, Xiaoyu Shi, Li Wang, Zhigang Liu, Tieshan Teng
{"title":"抗K1肺炎克雷伯菌噬菌体Henu2_3的鉴定、基因组学及动物模型疗效研究","authors":"Qiming Li, Jiaqi Li, Yanyang Zhao, Shuai Guo, Mengzhe Liu, Xiaoyu Shi, Li Wang, Zhigang Liu, Tieshan Teng","doi":"10.1186/s13568-025-01919-0","DOIUrl":null,"url":null,"abstract":"<p><p>The emergence and spread of multidrug-resistant and super-resistant bacterial strains have positioned phage therapy as a highly promising approach for future infection treatments. Klebsiella pneumoniae, a leading cause of clinical infections and hospital-acquired diseases, is responsible for over 95% of infections within the Klebsiella genus. Phages targeting K. pneumoniae exhibit remarkable diversity, with numerous isolates identified against various serotypes of this pathogen. In this study, we described the isolation and characterization of a novel bacteriophage from hospital sewage, Henu2_3, which targeted clinical isolates of K1-type K. pneumoniae. Transmission electron microscopy revealed that phage Henu2_3 possessed an icosahedral head and podovirus morphotype. The phage genome comprises 42,878 base pairs with a G + C content of 53.97%, encoding 54 putative open reading frames. One-step growth curve analysis demonstrated that phage Henu2_3 has a latency period of 10 min and an average burst size of 215 phage particles per infected cell. Additionally, Henu2_3 exhibited remarkable stability, tolerating temperatures up to 60℃ and maintaining maximum viability across a broad pH range of 4 to 12. In vivo infection models demonstrated that phage Henu2_3 markedly enhanced animal survival and decreased bacterial burden in target organs. These properties highlight its potential as a therapeutic agent against K. pneumoniae infections.</p>","PeriodicalId":7537,"journal":{"name":"AMB Express","volume":"15 1","pages":"112"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311074/pdf/","citationCount":"0","resultStr":"{\"title\":\"Characterization and genomics of phage Henu2_3 against K1 Klebsiella pneumoniae and its efficacy in animal models.\",\"authors\":\"Qiming Li, Jiaqi Li, Yanyang Zhao, Shuai Guo, Mengzhe Liu, Xiaoyu Shi, Li Wang, Zhigang Liu, Tieshan Teng\",\"doi\":\"10.1186/s13568-025-01919-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The emergence and spread of multidrug-resistant and super-resistant bacterial strains have positioned phage therapy as a highly promising approach for future infection treatments. Klebsiella pneumoniae, a leading cause of clinical infections and hospital-acquired diseases, is responsible for over 95% of infections within the Klebsiella genus. Phages targeting K. pneumoniae exhibit remarkable diversity, with numerous isolates identified against various serotypes of this pathogen. In this study, we described the isolation and characterization of a novel bacteriophage from hospital sewage, Henu2_3, which targeted clinical isolates of K1-type K. pneumoniae. Transmission electron microscopy revealed that phage Henu2_3 possessed an icosahedral head and podovirus morphotype. The phage genome comprises 42,878 base pairs with a G + C content of 53.97%, encoding 54 putative open reading frames. One-step growth curve analysis demonstrated that phage Henu2_3 has a latency period of 10 min and an average burst size of 215 phage particles per infected cell. Additionally, Henu2_3 exhibited remarkable stability, tolerating temperatures up to 60℃ and maintaining maximum viability across a broad pH range of 4 to 12. In vivo infection models demonstrated that phage Henu2_3 markedly enhanced animal survival and decreased bacterial burden in target organs. These properties highlight its potential as a therapeutic agent against K. pneumoniae infections.</p>\",\"PeriodicalId\":7537,\"journal\":{\"name\":\"AMB Express\",\"volume\":\"15 1\",\"pages\":\"112\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311074/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AMB Express\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1186/s13568-025-01919-0\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AMB Express","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1186/s13568-025-01919-0","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Characterization and genomics of phage Henu2_3 against K1 Klebsiella pneumoniae and its efficacy in animal models.
The emergence and spread of multidrug-resistant and super-resistant bacterial strains have positioned phage therapy as a highly promising approach for future infection treatments. Klebsiella pneumoniae, a leading cause of clinical infections and hospital-acquired diseases, is responsible for over 95% of infections within the Klebsiella genus. Phages targeting K. pneumoniae exhibit remarkable diversity, with numerous isolates identified against various serotypes of this pathogen. In this study, we described the isolation and characterization of a novel bacteriophage from hospital sewage, Henu2_3, which targeted clinical isolates of K1-type K. pneumoniae. Transmission electron microscopy revealed that phage Henu2_3 possessed an icosahedral head and podovirus morphotype. The phage genome comprises 42,878 base pairs with a G + C content of 53.97%, encoding 54 putative open reading frames. One-step growth curve analysis demonstrated that phage Henu2_3 has a latency period of 10 min and an average burst size of 215 phage particles per infected cell. Additionally, Henu2_3 exhibited remarkable stability, tolerating temperatures up to 60℃ and maintaining maximum viability across a broad pH range of 4 to 12. In vivo infection models demonstrated that phage Henu2_3 markedly enhanced animal survival and decreased bacterial burden in target organs. These properties highlight its potential as a therapeutic agent against K. pneumoniae infections.
期刊介绍:
AMB Express is a high quality journal that brings together research in the area of Applied and Industrial Microbiology with a particular interest in ''White Biotechnology'' and ''Red Biotechnology''. The emphasis is on processes employing microorganisms, eukaryotic cell cultures or enzymes for the biosynthesis, transformation and degradation of compounds. This includes fine and bulk chemicals, polymeric compounds and enzymes or other proteins. Downstream processes are also considered. Integrated processes combining biochemical and chemical processes are also published.